C. Lafarge‐Frayssinet
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 8
- Cancer, Hypoxia, and Metabolism 4
- Plant Science top 5%
- Mycotoxins in Agriculture and Food 14
- Insect Science top 5%
- Biotechnology top 10%
- Cancer Research and Treatments 8
-
- Liver physiology and pathology 7
-
- Growth Hormone and Insulin-like Growth Factors 5
-
- Amino Acid Enzymes and Metabolism 3
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- C FrayssinetYvonne RosensteinSabine MoussetP. LafontG LespinatsF LoisillierAmadou KaneG. Dirheimer
- Partner nations
- FranceUnited StatesPortugal
In The Last Decade
C. Lafarge‐Frayssinet
54 papers receiving 899 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 255
- Plant Science 601
- Immunology 195
- Insect Science 98
- Biotechnology 51
Countries citing papers authored by C. Lafarge‐Frayssinet
This map shows the geographic impact of C. Lafarge‐Frayssinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lafarge‐Frayssinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lafarge‐Frayssinet more than expected).
Fields of papers citing papers by C. Lafarge‐Frayssinet
This network shows the impact of papers produced by C. Lafarge‐Frayssinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lafarge‐Frayssinet. The network helps show where C. Lafarge‐Frayssinet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Lafarge‐Frayssinet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 6 | |
| 2 | 2006 | 4 | |
| 3 | 1998 | 32 | |
| 4 | 1998 | 12 | |
| 5 | 1997 | 13 | |
| 6 | [Immunotherapy of tumors expressing IGF-I]. | 1996 | 2 |
| 7 | 1994 | 14 | |
| 8 | In vitro evaluation of the differential cytotoxicity of keto-C-glycosides toward normal and malignant cells. | 1993 | 1 |
| 9 | 1992 | 2 | |
| 10 | 1991 | 30 | |
| 11 | 1990 | 1 | |
| 12 | 1990 | 1 | |
| 13 | 1990 | 15 | |
| 14 | 1990 | 16 | |
| 15 | 1990 | 6 | |
| 16 | 1989 | 18 | |
| 17 | 1988 | 7 | |
| 18 | 1988 | 52 | |
| 19 | 1985 | 6 | |
| 20 | 1981 | 16 |
About C. Lafarge‐Frayssinet
C. Lafarge‐Frayssinet is a scholar working on Biotechnology, Hepatology and Cancer Research, having authored 54 papers that have together received 976 indexed citations. Recurring topics across this work include Mycotoxins in Agriculture and Food (14 papers), Cancer Research and Treatments (8 papers), Carcinogens and Genotoxicity Assessment (8 papers), Liver physiology and pathology (7 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Cancer Research (255 citations), Plant Science (601 citations) and Immunology (195 citations). C. Lafarge‐Frayssinet has collaborated with scholars based in France, United States and Portugal. Frequent co-authors include C Frayssinet, Yvonne Rosenstein, Sabine Mousset, P. Lafont, G Lespinats, F Loisillier, Amadou Kane, G. Dirheimer, E.E. Creppy and Huguette Cohen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.